AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (March 22, 2005). doi:10.1152/ajpendo.00006.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/2/E313    most recent
00006.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parnaud, G.
Right arrow Articles by Bosco, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parnaud, G.
Right arrow Articles by Bosco, D.
Submitted on January 7, 2005
Accepted on March 14, 2005

Inhibition of calpain blocks pancreatic beta-cell spreading and insulin secretion

Geraldine Parnaud1*, Eva Hammar1, Dominique G Rouiller1, and Domenico Bosco2

1 Department of Genetic Medicine and Development, University Medical Center, Geneva, Switzerland
2 Cell Isolation and Transplantation Center, Division of Surgical Research, Department of Surgery, University Hospital, Geneva, Switzerland

* To whom correspondence should be addressed. E-mail: geraldine.parnaud{at}medecine.unige.ch.

In addition to promoting insulin secretion, an increase in cytosolic Ca2+ triggered by glucose has been shown to be crucial for spreading of beta-cells attached on extracellular matrix (804G matrix). Calpains are Ca2+-dependent cysteine proteases involved in an extended spectrum of cellular responses, including cytoskeletal rearrangements and vesicular trafficking. The present work aimed to assess whether calpain is also implicated in the process of Ca2+-induced insulin secretion and spreading of rat pancreatic beta-cells. The results indicate calpain dependency of beta-cell spreading on 804G matrix. Indeed treatment with three distinct calpain inhibitors (ALLN, Calpeptin, EST) inhibited cell spreading induced by glucose and KCl, whereas cell attachment was not significantly modified. Calpain inhibitors also suppressed glucose- and KCl-stimulated insulin secretion without affecting insulin synthesis. Washing the inhibitor out of the cell culture restored spreading on 804G matrix and insulin secretory response after 24 hours. In addition, incubation with Calpeptin did not affect insulin secretory response to Mastoparan that acts on exocytosis downstream of intracellular calcium [Ca2+]i. Finally, Calpeptin was shown to affect the [Ca2+]i response to glucose but not to KCl. In summary, the results show that inhibition of calpain blocks spreading and insulin secretion of primary beta pancreatic cells. It is therefore suggested that calpain could be a mediator of Ca2+-induced-insulin secretion and beta-cell spreading.




This article has been cited by other articles:


Home page
J EndocrinolHome page
E. Aganna, J. M Burrin, G. A Hitman, and M. D Turner
Involvement of calpain and synaptotagmin Ca2+ sensors in hormone secretion from excitable endocrine cells.
J. Endocrinol., September 1, 2006; 190(3): R1 - R7.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. J. Franco and A. Huttenlocher
Regulating cell migration: calpains make the cut
J. Cell Sci., September 1, 2005; 118(17): 3829 - 3838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.